(Total Views: 264)
Posted On: 08/25/2021 3:25:50 PM
Post# of 65

$EBS News Article - Emergent BioSolutions' COVID-19 Human Immune Globulin Product Candidate to be Evaluated in NIH-Sponsored Phase 3 Clinical Trial (INSIGHT-012) of Hyperimmune Intravenous Immunoglobulin for Outpatient Treatment of COVID-19 https://marketwirenews.com/news-releases/emer...83562.html


My Twitter: WhyteStocks